RA Information Library

Info Sheet: Abatacept (Orencia)
  1. Information, questions and answers related to: Abatacept (Orencia).

  2. Bristol-Myers says FDA broadens label for Orencia

    NEW YORK -- Bristol-Myers Squibb Co. said Wednesday regulators approved a change in the labeling of the rheumatoid arthritis drug Orencia.

    The FDA approved an addition to the label that says studies show Orencia is effective for patients who have had the disease for two years or less.

    Read More: http://www.forbes.com/feeds/ap/2009/08/26/business-health-care-us-bristol-myers-squibb-orencia_6817041.html

Add a Post

Log In required in order to post to the RA Information Library.
Don't have an account yet? Register now!

RSS feed for "Info Sheet: Abatacept (Orencia)"